Abstract
Comprehensive genomic profiling (CGP) has become the cornerstone of personalised oncology treatment. Therapeutic approaches based distinctively to patients’ demographics, prior treatment and genomic profiles are now being investigated in clinical trials. Access to suitable trials have also shown to improve outcome. Current trial subject recruitment process is hampered by manual examination of eligibility criteria. An automated decision support system coupled with CGP may help increase clinical trials recruitment and reduce screen failure rates.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
